FDA Approves First Non-Hormonal Drug for Treating Hot Flashes

by Kathy Jones on  June 29, 2013 at 7:58 PM Drug News   - G J E 4
The US Food and Drug Administration has approved the first non-hormonal drug for treating hot flashes even though an advisory committee had voted against such an approval back in March.
 FDA Approves First Non-Hormonal Drug for Treating Hot Flashes
FDA Approves First Non-Hormonal Drug for Treating Hot Flashes

The drug will be manufactured by Noven Pharmaceuticals and will be marketed under the name Brisdelle and contains low dosage of paroxetine, used in higher quantities in the antidepressant drug Paxil.

The advisory committee had voted 10-4 recommending against an approval for the drug back in March, stating that while there was a need for a non-hormonal treatment for hot flashes, Noven's drug was only minimally effective.

Stating that there were a large number of women who did not want to use hormonal treatments for hot flashes, FDA's director of the F.D.A's division of bone, reproductive and urologic products Dr Hylton V. Joffe said, "There are a significant number of women who suffer from hot flashes associated with menopause and who cannot or do not want to use hormonal treatments. Today's approval provides women with the first FDA-approved, non-hormonal therapeutic option to help ease the hot flashes that are so common in menopause."

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like